相关实验视频

Updated: Jul 21, 2025

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

患者和专业人士在英国和澳大利亚使用体外受精补充剂的观点:定性研究

Sarah C Armstrong^1,2, Emily Vaughan³, Sarah Lensen⁴

¹Oncology and Metabolism, The University of Sheffield Faculty of Medicine, Dentistry and Health, Sheffield, UK scarmstrong1@sheffield.ac.uk.

|July 26, 2023

概括

患者通常基于希望决定体外受精 (IVF) 补充剂,而临床医生优先考虑患者的财务状况和结果. 两组都发现证据应用具有挑战性,强调需要改善患者专业话语和关于试管婴儿补充剂的知情同意.

科学领域:

生殖医学生殖医学
质量健康研究质量健康研究
患者的决策能力

背景情况:

试管受精 (IVF) 补充剂经常被提供以提高活产率,但由于有效性和安全性的证据有限,以及额外的成本,这些补充剂存在争议.
尽管存在争议,但试管婴儿补充剂很受欢迎,但对其使用和决策过程的定性研究很少.

研究的目的:

调查使用或推试管婴儿补充剂的决策过程.
确定患者和专业人员使用关于试管婴儿补充剂的信息来源.
探索有关IVF补充剂的安全性和有效性的担忧.

主要方法:

价值研究采用了定性,半结构面试设计.
在匿名采访成绩单上使用了诱导性主题分析.
参与者包括来自英国和澳大利亚的患者 (n=25) 和卫生专业人员 (胚胎学家n=25,临床医生n=24).

主要成果:

患者对试管婴儿补充剂的决定往往是由希望驱动的,不太强调安全性,有效性或成本.
医疗保健专业人员的目标是获得最佳的患者结果,并防止财务浪费,并将附加组件的使用视为患者驱动.
无论是患者还是专业人士,都发现很难将现有证据应用于试管婴儿高风险领域的个人情况.

结论:

需要提高患者和医疗保健专业人员之间关于试管婴儿补充剂的沟通和话语的质量.
患者在与试管婴儿补充剂有关的决定中重视自主权.
对于医疗保健专业人员来说,在讨论试管婴儿补充剂时,确保全面的知情同意至关重要,无论他们对其使用的立场如何.

关键词:

质量研究质量研究生殖医学是一种生殖医学.亚生育能力不能生育

更多相关视频

Human Blastocyst Biopsy and Vitrification

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Fertilization

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...